FDA issued recall of Infants’ Ibuprofen Concentrated Oral Suspension by Tris Pharma due to potential higher concentrations of ibuprofen; three additional lots added.
FDA issued recall of Synergy Cranial software and Stealth Station S7 Cranial software by Medtronic due to inaccuracies displayed during surgical procedures.
FDA issued recall of CAmlodipine/Valsartan Tablets USP, Valsartan/HCTZ Tablets, USP and Valsartan Tablets USP by Aurobindo due to NDEA (N-Nitrosodiethylamine) impurity.